From GlobeNewswire: 2024-11-21 01:30:00

Custom Market Insights has released a report on the global Apheresis Equipment Market, projecting its value to reach around USD 13,169.1 Million by 2033 with a CAGR of 12.2%. Factors driving growth include rising chronic diseases, technological advancements, aging population, expanded indications, increased demand for blood components, supportive healthcare policies, and growing awareness. Companies like TERUMO BCT, INC. and Fresenius Kabi AG have made significant contributions to the industry through partnerships and expansions. The report covers market size, growth trends, key segments, and regional scope. The Apheresis Equipment Market report for 2024 includes a detailed analysis, COVID-19 impact study, and updated regional data. The pandemic disrupted medical procedures and supply chains, but as elective treatments resume, telemedicine and safety measures improve patient care. Government support, technological advancements, and industry collaborations are driving market recovery post-pandemic. The COVID-19 pandemic has impacted the Apheresis Equipment Market, presenting both challenges and opportunities. Key questions answered in the report include market size, growth rate, top companies, market segments, fastest-growing regions, and the role of essential players in the value chain.

Key offerings in the report include market share, forecast by revenue, market dynamics, growth drivers, market segmentation, and competitive landscape analysis. Buyers can access a premium research report with fast delivery options.

Apheresis Equipment Market is analyzed regionally, with North America leading in adoption due to advanced healthcare infrastructure. Europe shows steady growth, Asia-Pacific experiences rapid expansion, and LAMEA sees increasing adoption amidst developing healthcare infrastructure.

Prominent players in the Apheresis Equipment Market include Terumo BCT Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, and others. Access a free sample report to explore market insights and trends from top industry players.

Spectacular deals are available for buyers, including comprehensive coverage, market tables and figures, subscription-based options, best price guarantee, customization hours, post-sale service assistance, discounts, service guarantees, and personalized market briefings. 1. The stock market reached record highs today, with the S&P 500 closing at a new all-time high of 4,500 points. This increase was driven by strong corporate earnings reports and optimism about the economy’s recovery from the pandemic.

2. In other news, the latest jobs report showed that the unemployment rate fell to 5.2% in August, the lowest level since the start of the pandemic. The economy added 235,000 jobs last month, surpassing expectations and signaling a strong labor market.

3. A new study found that global carbon emissions are on track to reach a record high in 2023, despite efforts to reduce greenhouse gas emissions. The report highlights the urgent need for more aggressive climate action to avoid the worst impacts of climate change.

4. The FDA approved a third dose of the Pfizer-BioNTech COVID-19 vaccine for certain groups, including people over 65 and those at high risk for severe illness. The decision comes as cases of the Delta variant continue to rise, prompting concerns about waning immunity.

5. Researchers discovered a new species of dinosaur in Argentina, named Llukalkan aliocranianus. This carnivorous dinosaur had a unique skull shape and is believed to have roamed the Earth during the Late Cretaceous period. The discovery sheds new light on the diversity of dinosaurs in South America. 1. The stock market reached record highs today, with the S&P 500 hitting a new peak of 4,525.68. This surge was driven by strong corporate earnings reports and positive economic data, boosting investor confidence.

2. The CDC announced that over 70% of adults in the US have received at least one dose of the COVID-19 vaccine. This milestone comes as the country continues to push for widespread vaccination to curb the spread of the virus.

3. Tesla reported a 98% increase in revenue for the second quarter, reaching $11.96 billion. The electric car company also delivered a record number of vehicles, totaling 201,250 in the same period, exceeding analysts’ expectations.

4. The Tokyo Olympics officially kicked off with the opening ceremony, featuring a scaled-down event due to COVID-19 restrictions. Athletes from around the world paraded in the Olympic Stadium, marking the start of the highly anticipated games.

5. The US economy added 943,000 jobs in July, exceeding expectations and signaling a strong recovery from the pandemic-induced downturn. The unemployment rate also dropped to 5.4%, down from 5.9% in June, reflecting a positive trend in the labor market. 1. The FDA has approved a new drug for treating migraines, with studies showing a significant reduction in frequency and severity of headaches. This new medication is expected to provide relief for millions of sufferers.

2. A recent study found that 70% of Americans are not saving enough for retirement, with many relying solely on Social Security benefits. Financial advisors are urging individuals to start saving early and contribute regularly to retirement accounts.

3. The unemployment rate has dropped to 4%, the lowest it has been in 20 years. This is attributed to a strong job market and increased consumer spending, particularly in the retail and healthcare industries. Economists are optimistic about continued growth in the labor market.

4. A new report reveals that over 1 million species are at risk of extinction due to human activities, such as deforestation and climate change. Conservation efforts are being called for to protect biodiversity and prevent irreversible damage to ecosystems. Scientists warn of dire consequences if action is not taken.



Read more at GlobeNewswire: [Latest] Global Apheresis Equipment Market Size/Share Worth